SLC16A3 and intrahepatic cholangiocarcinoma: Although the relationship between SLC16A3 and cholestasis pathogenesis is unclear, recent research has identified this gene as a potential prognostic biomarker related to intrahepatic cholangiocarcinoma cell reprogramming (Dong et al. 2022).